18F-fluorofuranylnorprogesterone PET / MRI

DRUG2 trials

Sponsors

University of North Carolina, Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Conditions

Complex Atypical HyperplasiaEndometrial CancerEndometriosis

Phase 2

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

Active, not recruitingNCT05480995

University of North Carolina, Chapel HillEndometriosis

Start: 2023-01-17End: 2026-08-01Updated: 2026-08-28

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

WithdrawnNCT05483023

UNC Lineberger Comprehensive Cancer CenterComplex Atypical Hyperplasia, Endometrial Cancer

Start: 2024-02-15End: 2027-12-31Updated: 2025-10-14